NCT02492009

Brief Summary

The proposed study is a pilot randomized controlled trial (RCT) of an electronic patient decision aid (PDA) for antidepressant use in pregnancy. The overall aim of this pilot RCT is to establish the feasibility of future large international RCT of the PDA's effectiveness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Jun 2015

Typical duration for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

June 22, 2015

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 8, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

October 27, 2021

Status Verified

September 1, 2016

Enrollment Period

1.8 years

First QC Date

June 22, 2015

Last Update Submit

October 20, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility, measured by 'Recruitment Rate'

    Up to one year from when the study starts enrolling participants

Secondary Outcomes (11)

  • Depression, measured by the Edinburgh Postnatal Depression Scale

    (a) Baseline (pre-randomization) and (b) 4 Weeks post-randomization and (c) 12 weeks postpartum (for participants who enrolled while pregnant) OR 6 months post-randomization (for women who enrolled while planning a pregnancy)

  • Anxiety, measured by the Spielburg State-Trait Anxiety Inventory

    (a) Baseline (pre-randomization) and (b) 4 Weeks post-randomization and (c) 12 weeks postpartum (for participants who enrolled while pregnant) OR 6 months post-randomization (for women who enrolled while planning a pregnancy)

  • Decisional conflict, measured by the Decisional Conflict Scale

    Baseline (pre-randomization) and 4 Weeks post-randomization

  • Knowledge about antidepressant treatment in pregnancy

    Baseline (pre-randomization) and 4 Weeks post-randomization

  • Intervention acceptability to patients, measured by the PDA Acceptability Questionnaire

    4 Weeks post-randomization]

  • +6 more secondary outcomes

Study Arms (2)

Standard Resource Sheet

PLACEBO COMPARATOR

Women allocated to the control intervention will login to the study website and receive a printable PDF containing references to standard published information on antidepressant use in pregnancy. This ensures women have access to accurate information on the benefits and risks of antidepressant medication in pregnancy (even though they will not receive the PDA).

Behavioral: Standard Resource Sheet

Electronic Patient Decision Aid

ACTIVE COMPARATOR

The electronic Patient Decision Aid (PDA) is an interactive website with 3 main sections: 1. Evidence-based information on (a) depression in pregnancy, (b) each treatment option and procedure; 2. (a) Evidence-based information on the risks and benefits of both untreated depression and antidepressant treatment, (b) exercises to help women determine which risks and benefits are most important to them; and 3. A summary section that outlines the information reviewed and which benefits and risks they deemed most important. At the end of the PDA, women allocated to this intervention will ALSO receive the standard resource sheet which is being used as the placebo comparator.

Behavioral: Patient Decision Aid

Interventions

Women allocated to the control intervention will login to the study website and receive a printable PDF containing references to standard published information on antidepressant use in pregnancy. This ensures women have access to accurate information on the benefits and risks of antidepressant medication in pregnancy (even though they will not receive the PDA).

Standard Resource Sheet

The electronic Patient Decision Aid (PDA) is an interactive website with 3 main sections: 1. Evidence-based information on (a) depression in pregnancy, (b) each treatment option and procedure; 2. (a) Evidence-based information on the risks and benefits of both untreated depression and antidepressant treatment, (b) exercises to help women determine which risks and benefits are most important to them; and 3. A summary section that outlines the information reviewed and which benefits and risks they deemed most important. At the end of the PDA, women allocated to this intervention will ALSO receive the standard resource sheet which is being used as the placebo comparator.

Electronic Patient Decision Aid

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Are aged over 18
  • Are planning a pregnancy or are \<30 weeks pregnant at enrolment
  • Have been offered to start or continue an antidepressant as treatment for depression by their clinician a
  • Have moderate-to-high decisional conflict (score of \>25 on the Decisional Conflict Scale)

You may not qualify if:

  • Have had alcohol or drug abuse or dependence in the previous 12 months
  • Have active suicidal ideation or psychosis
  • Are incapable of consenting to participation
  • Have any major obstetric complications or foetal cardiac anomaly in the current or in a past pregnancy,
  • Are visually impaired
  • Do not have sufficient English language proficiency to use the PDA.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South London and Maudsley NHS Foundation Trust

London, SE5 8AF, United Kingdom

Location

Related Publications (1)

  • Khalifeh H, Molyneaux E, Brauer R, Vigod S, Howard LM. Patient decision aids for antidepressant use in pregnancy: a pilot randomised controlled trial in the UK. BJGP Open. 2019 Dec 10;3(4):bjgpopen19X101666. doi: 10.3399/bjgpopen19X101666. Online ahead of print.

Related Links

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Louise M Howard, PhD

    Section of Women's Mental Health, King's College London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2015

First Posted

July 8, 2015

Study Start

June 1, 2015

Primary Completion

March 1, 2017

Study Completion

November 1, 2017

Last Updated

October 27, 2021

Record last verified: 2016-09

Locations